Themoula Charalampous
- Clinical Biochemistry top 2%
- Bacterial Identification and Susceptibility Testing 3
- Molecular Medicine top 5%
- Microbiology top 10%
-
- Pneumonia and Respiratory Infections 2
- Infective Endocarditis Diagnosis and Management 2
-
- SARS-CoV-2 and COVID-19 Research 3
- COVID-19 Clinical Research Studies 3
-
- Genomics and Phylogenetic Studies 3
- Gut microbiota and health 2
-
- Bacteriophages and microbial interactions 2
- Co-authors
- Justin O’GradyRichard M. LeggettChristopher JeanesJohn WainAlp AydinHollian RichardsonDaniel J. TurnerGemma L. Kay
- Journals
- SHILAP Revista de lepidopterología (1 paper)Nature Biotechnology (1 paper)Clinical Infectious Diseases (1 paper)
- Partner nations
- United KingdomUnited StatesRussia
In The Last Decade
Themoula Charalampous
13 papers receiving 613 citations
Hit Papers
Peers
Comparison fields: 5 of 75
- Clinical Biochemistry 163
- Molecular Medicine 83
- Microbiology 47
- Critical Care and Intensive Care Medicine 38
- Epidemiology 222
Countries citing papers authored by Themoula Charalampous
This map shows the geographic impact of Themoula Charalampous's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Themoula Charalampous with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Themoula Charalampous more than expected).
Fields of papers citing papers by Themoula Charalampous
This network shows the impact of papers produced by Themoula Charalampous. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Themoula Charalampous. The network helps show where Themoula Charalampous may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Themoula Charalampous, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2024 | 8 | |
| 3 | 2023 | 6 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 5 | |
| 6 | 2022 | 6 | |
| 7 | 2022 | 9 | |
| 8 | 2022 | 3 | |
| 9 | 2022 | 19 | |
| 10 | 2021 | 1 | |
| 11 | 2020 | 66 | |
| 12 | 2019 | 63 | |
| 13 | Nanopore metagenomics enables rapid clinical diagnosis of bacterial lower respiratory infectionbreakdown → | 2019 | 420 |
| 14 | 2018 | 4 |
About Themoula Charalampous
Themoula Charalampous is a scholar working on Microbiology, Clinical Biochemistry and Critical Care and Intensive Care Medicine, having authored 14 papers that have together received 615 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (3 papers), Bacterial Identification and Susceptibility Testing (3 papers), COVID-19 Clinical Research Studies (3 papers), Genomics and Phylogenetic Studies (3 papers), Bacteriophages and microbial interactions (2 papers), Pneumonia and Respiratory Infections (2 papers), Infective Endocarditis Diagnosis and Management (2 papers) and Gut microbiota and health (2 papers). The work is most often cited by research in Clinical Biochemistry (163 citations), Molecular Medicine (83 citations) and Microbiology (47 citations). Themoula Charalampous has collaborated with scholars based in United Kingdom, United States and Russia. Frequent co-authors include Justin O’Grady, Richard M. Leggett, Christopher Jeanes, John Wain, Alp Aydin, Hollian Richardson, Daniel J. Turner, Gemma L. Kay, David M. Livermore and Rossella Baldan. Their work appears in journals such as SHILAP Revista de lepidopterología, Nature Biotechnology and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.